Journal Club: All Recent News

Daewoong Pharma launches Herceptin biosimilar in Korea

(Mar 5 2018)

Pharma's biggest selling drugs - opportunity knocks for biosimilars

(Mar 4 2018)

STADA: EMA started the evaluation of resubmitted marketing authorisation application for biosimilar pegfilgrastim

(Mar 2 2018)

European Authorities Approve JHL Biotech's Clinical Trial Application for Dornase Alfa Biosimilar to Affordably Manage Symptoms of Cystic Fibrosis

(Mar 1 2018)

Mylan partners with Revance Therapeutics to develop Botox biosimilar

(Feb 28 2018)

Mylan to Bring a Biosimilar of BOTOX to the Market Through a Collaboration and License agreement with Revance Therapeutics

(Feb 28 2018)

Europe Approves JHL Biotech's Clinical Trial Application for Bevacizumab Biosimilar to Affordably Treat Colorectal, Lung, and Ovarian Cancers

(Feb 22 2018)

Merck KGaA, Darmstadt, Germany Invests Additional $47 Million to Enhance Manufacturing and Distribution in Asia

(Feb 21 2018)

Russian infliximab biosimilar has been proved equivalent to Remicade in international clinical trials

(Feb 20 2018)

Viewpoints: Will Humira biosimilars launch in Europe this year?

(Feb 19 2018)

CT-P13 (biosimilar infliximab) is comparable to reference infliximab and adalimumab in highly anticipated real-world study

(Feb 18 2018)

FDA vows to combat high drug prices and companies 'gaming the system'

(Feb 16 2018)

Celltrion Receives EU Approval for Trastuzumab Biosimilar

(Feb 14 2018)

Drug copies ready to take next bite out of Roche's cancer sales

(Feb 13 2018)

South Dakota Governor Daugaard Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines

(Feb 11 2018)

Foreigners, institutions back Celltrion

(Feb 11 2018)

Lupin's JV completes global trials for RA biosimilar

(Feb 7 2018)

ViewPoints: Does Roche's biosimilar math add up?

(Feb 4 2018)

JHL Biotech’s Application to Voluntarily Terminate Trading of Shares Approved by Taipei Exchange

(Feb 4 2018)

Celltrion CEO denies inflating earnings

(Feb 2 2018)

Pages